Teva Pharmaceutical Industries Ltd banner

Teva Pharmaceutical Industries Ltd
NYSE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd Logo
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Watchlist
Price: 38.945 USD -0.63% Market Closed
Market Cap: $44.1B

Wall St Price Targets

TEVA Price Forecast
No price targets yet

We don't have analyst price targets for TEVA yet.

TEVA Analyst Rating
Based on 11 analysts

avg. 4.45 of 5
Strong buy
6 55%
Buy
4 36%
Hold
1 9%
Sell
0 0%
Strong sell
0 0%

Analysts rate TEVA Buy, with 10 of 11 recommending Buy or Strong buy.

Teva Pharmaceutical Industries Ltd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TEVA's stock price target?
Not Available

TEVA does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 8 years is 3%.

What is the Gross Profit forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 8 years is 4%.

What is the Operating Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 7%.

What is the Pre-Tax Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
61%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 61%.

What is the Net Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 8 years is 20%.

Back to Top